Back to MW MARSHALL WACE, LLP

PYXSPYXS
Showing 8 of 9 quarters

Position history for MWMARSHALL WACE, LLP's holdings in PYXIS ONCOLOGY INC

MARSHALL WACE, LLP holds 354,417 shares of PYXS (PYXIS ONCOLOGY INC), worth $517,448 as of 2026-Q1. The position was decreased (-9.1% shares). PYXS represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$517,448

Current Shares

354,417

Total Value Change

+$484,348

Total Shares Change

+344,417

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
354,417
-9.1%
$517,4480.0%$1.43
0
2025-Q4
New
389,764
-
$448,2290.0%$1.09
33
2025-Q3
Exited
0
-100.0%
$00.0%$2.20
0
2025-Q2
New
147,771
-
$162,5490.0%$1.10
31
2025-Q1
Exited
0
-100.0%
$00.0%$1.06
0
2024-Q4
Increased
157,953
+35.8%
$246,4070.0%$1.56
30
2024-Q3
Increased
116,359
+1063.6%
$427,0370.0%$3.62
39
2024-Q2
Decreased
10,000
-92.5%
$33,1000.0%$3.31
0

Other major holders of PYXS: RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, CITADEL ADVISORS LLC, Janus Henderson Group Ltd., BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used